Blonder Tongue Laboratories, Inc.
BDRL
$0.1895
$0.09396.37%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 14.99% | 4.61% | -2.16% | 1.69% | -3.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.99% | 4.61% | -2.16% | 1.69% | -3.82% |
| Cost of Revenue | 27.85% | 8.56% | -8.38% | -11.07% | -25.93% |
| Gross Profit | -6.74% | -4.17% | 15.33% | 40.57% | 94.10% |
| SG&A Expenses | -6.57% | -14.12% | -16.84% | -17.36% | -18.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 391.44% | -- | -- | -- |
| Total Operating Expenses | 1.75% | 9.58% | -5.41% | -6.46% | -15.30% |
| Operating Income | 48.56% | -30.24% | 14.98% | 27.78% | 41.73% |
| Income Before Tax | -3,050.51% | -182.84% | -15.07% | 88.93% | 101.33% |
| Income Tax Expenses | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | -3,577.38% | -180.88% | -14.99% | 88.71% | 101.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,577.38% | -180.88% | -14.99% | 88.71% | 101.12% |
| EBIT | 48.56% | -30.24% | 14.98% | 27.78% | 41.73% |
| EBITDA | 47.25% | -37.18% | 14.20% | 28.90% | 43.90% |
| EPS Basic | -2,105.45% | -99.14% | 16.83% | 92.80% | 101.46% |
| Normalized Basic EPS | 20.43% | -48.38% | 12.74% | 42.54% | 63.08% |
| EPS Diluted | -527.17% | -74.25% | 17.08% | 84.76% | 95.28% |
| Normalized Diluted EPS | 19.69% | -49.67% | 12.26% | 42.98% | 63.42% |
| Average Basic Shares Outstanding | 9.31% | 13.78% | 17.64% | 20.72% | 22.74% |
| Average Diluted Shares Outstanding | 2.42% | 6.25% | 9.45% | 28.61% | 31.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
